Lobbying disclosures · Lobbying report
CAH: second_quarter 2026 lobbying report
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preservin
Follow CAH- Became public
- Jul 20, 2026, 10:07 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 6:50 AM EST
Why this is connected
Exact legal-name match: CARDINAL HEALTH INC (https://www.sec.gov/Archives/edgar/data/721371/).
Reported lobbying amounts
Expenses: $460,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/c8c363ce-e664-4a75-bb45-b906f92d691d/","filing_uuid":"c8c363ce-e664-4a75-bb45-b906f92d691d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c8c363ce-e664-4a75-bb45-b906f92d691d/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rebecca McGrath","dt_posted":"2026-07-20T10:07:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7000 CARDINAL PLACE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"DUBLIN","registrant_state":"OH","registrant_zip":"43017","registrant":{"id":58055,"url":"https://lda.gov/api/v1/registrants/58055/","house_registrant_id":35261,"name":"CARDINAL HEALTH, INC.","description":null,"address_1":"7000 CARDINAL PLACE","address_2":null,"address_3":null,"address_4":null,"city":"DUBLIN","state":"OH","state_display":"Ohio","zip":"43017","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"REBECCA MCGRATH","contact_telephone":"+1 202-258-3789","dt_updated":"2026-07-30T08:49:35.442205-04:00"},"client":{"id":160433,"url":"https://lda.gov/api/v1/clients/160433/","client_id":12,"name":"CARDINAL HEALTH INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90710,"prefix":null,"prefix_display":null,"first_name":"JERRICA","nickname":null,"middle_name":null,"last_name":"MATHIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90710,"prefix":null,"prefix_display":null,"first_name":"JERRICA","nickname":null,"middle_name":null,"last_name":"MATHIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs, trade, and U.S. trade policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90710,"prefix":null,"prefix_display":null,"first_name":"JERRICA","nickname":null,"middle_name":null,"last_name":"MATHIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to tariffs, trade, and U.S. trade policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90710,"prefix":null,"prefix_display":null,"first_name":"JERRICA","nickname":null,"middle_name":null,"last_name":"MATHIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in CAH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 28, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Oct 24, 2025 · disclosed Oct 28, 2025
- May 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 14, 2025 · disclosed May 19, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- May 6, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 5, 2025 · disclosed May 6, 2025
- Mar 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Mar 17, 2025 · disclosed Mar 19, 2025
- Jan 27, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jan 21, 2025 · disclosed Jan 27, 2025
- Sep 23, 2024$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Sep 20, 2024 · disclosed Sep 23, 2024
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.